Skip to content

A Participant Observation Study on Patients with Parkinson’s disease using Art Therapy

A Participant Observation Study on Patients with Parkinson’s disease using Art Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007483
Enrollment
14
Registered
2022-06-30
Start date
2021-06-10
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Among men and women diagnosed with Parkinson's disease, those with a score of 24 or higher on MMSE (Cognitive Function and Dementia Test) 2) Those who fall under the 1st to 3rd level of Hoehn and Yahr Scale *Use a scale of 1 to 5 as the degree of dysfunction in Parkinson's disease. - Stage 1: Symptoms appear on only one side of the trunk. - Stage 2: Symptoms appear on both sides of the trunk, and there is no disturbance of balance. - Stage 3: Balance is impaired. There is a mild degree of progression and is physically dependent. - Stage 4: Severe dysfunction is present, but it is still possible without assistance in walking or standing. - Stage 5: Reliance on a wheelchair or living in bed and having difficulty in activities without assistance 3) A person who has no problem with cognitive function, and who has voluntarily decided to participate in the study after hearing and fully understanding the detailed explanation of this study and consented to participate in the study through written consent

Exclusion criteria

Exclusion criteria: 1) In case of accompanying neurological disease other than Parkinson's disease, such as dementia, Huntington's disease, hydrocephalus 2) In case of gait disturbance due to stroke, brain tumor, or other brain disease 3) In case it is judged inappropriate by the judgment of other researchers 4) Those with a score of 23 or less on the MMSE (Cognitive Function and Dementia Test)

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's disease rating scale;Non-Motor Symptoms Scale for Parkinson's Disease;EQ-5D

Secondary

MeasureTime frame
Functional near-infrared spectroscopy;Qualitative evaluation of the results of art activities

Countries

Korea, Republic of

Contacts

Public ContactWang Jung Hur

Daejeon Korean Medicine Hospital of Daejeon University

xocius@gmail.com+82-42-470-9487

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026